Trial Profile
A Double-blind, Placebo-controlled, Parallel Design, Randomized, Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene Transfer in Males With Erectile Dysfunction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Maxi-K gene therapy (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Ion Channel Innovations
- 17 Jul 2019 Status changed from recruiting to completed.
- 22 Mar 2016 New trial record